2Y71 image
Deposition Date 2011-01-28
Release Date 2011-08-17
Last Version Date 2023-12-20
Entry Detail
PDB ID:
2Y71
Keywords:
Title:
Structure of Mycobacterium tuberculosis type II dehydroquinase complexed with (1R,4S,5R)-1,4,5-trihydroxy-3-((5-methylbenzo(b) thiophen-2-yl)methoxy)cyclohex-2-enecarboxylate
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.16
R-Value Work:
0.12
R-Value Observed:
0.12
Space Group:
F 2 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:3-DEHYDROQUINATE DEHYDRATASE
Chain IDs:A
Chain Length:146
Number of Molecules:1
Biological Source:MYCOBACTERIUM TUBERCULOSIS
Primary Citation
A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
J. Med. Chem. 54 6063 6084 (2011)
PMID: 21780742 DOI: 10.1021/jm2006063

Abstact

The synthesis of high-affinity reversible competitive inhibitors of Mycobacterium tuberculosis type II dehydroquinase, an essential enzyme in Mycobacterium tuberculosis bacteria, is reported. The inhibitors reported here are mimics of the enol intermediate and the effect of substitution on C2 was studied. The crystal structures of Mycobacterium tuberculosis type II dehydroquinase in complex with three of the reported inhibitors are also described. The results show that an aromatic substituent on C2 prevents the closure of the active site by impeding the hydrogen-bonding interaction of Arg108 with the essential Tyr24 of the flexible loop, the residue that initiates catalysis. Chemical modifications of the reported acids were also carried out to improve internalization into Mycobacterium tuberculosis through an ester prodrug approach. Propyl esters proved to be the most efficient in achieving optimal in vitro activities.

Legend

Protein

Chemical

Disease

Primary Citation of related structures